A Case of Pneumocystis carinii Pneumonia in a Patient with Behcet Syndrome.
- Author:
Ji Young JUNG
1
;
Suk Hoon CHOI
;
Yoon Seon PARK
;
Bum Sik JIN
;
Sang Hoon HAN
;
Hur Kyu YUN
;
Wan Sub SHIM
;
Jae Hyuk LEE
;
Sang Youn JUNG
;
Han Suk CHOI
;
Jun Yong CHOI
;
Yoon Soo PARK
;
Chung Ho CHO
;
Kyung Hee CHANG
;
Young Goo SONG
;
Kwang Hoon LEE
;
June Myung KIM
Author Information
1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea. mkim@yumc.yonsei.ac.kr
- Publication Type:Case Report
- Keywords:
Pneumocystis carinii;
Pneumocystis carinii pneumonia;
Immunocompromised host;
Behcet syndrome
- MeSH:
Arthritis, Rheumatoid;
Autoimmune Diseases;
Behcet Syndrome*;
Bone Marrow;
Hand;
HIV Infections;
Humans;
Immunocompromised Host;
Incidence;
Korea;
Pneumocystis carinii*;
Pneumocystis*;
Pneumonia, Pneumocystis*
- From:
Infection and Chemotherapy
2003;35(5):350-354
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Pneumocystis carinii pneumonia (PCP) is one of the most common causes of infection in patients with HIV infection. With the development of effective prophylactic agent, the incidence of PCP in patients with HIV infection has been declining. On the other hand, however, the incidence of PCP has been increasing in immunocompromised hosts without HIV infection, such as rheumatoid arthritis, bone marrow transplantaion and Behcet syndrome. The increased occurrence of PCP in non-HIV- infected subjects has been attributed to several factors, such as use of stronger immunosuppressive regimens, higher awareness of PCP, advanced diagnostic technology and nosocomial spread of P. carinii. The occurrence of PCP in patients who receive immunosuppressive drugs for autoimmune disease has not been well known in Korea. We report a patient with Behcet syndrome who suffered from PCP after immunosuppressive drugs.
